Continuous, Validated Cough Monitoring

Hyfe AI provides consistently reliable, high-quality data, collected unobtrusively, delivering precise insights and dependable results

Talk To a Cough Expert
Forbes logo. Hyfe - AI for humans: save lives, eradicate disease, and stop the next pandemic
The scientist logo. Hyfe - By using artificial intelligence, Hyfe tracks cough frequency and helps you identify cough trends
N logo. Hyfe - Take control of your respiratory health
DN logo. Hyfe - Measure cough as an objective clinical finding
Cope logo. Hyfe - Resources for Hyfe Research Partners
Navarra logo. Hyfe - Respiratory Care that Just Works
Johnson and Johnson logo. Hyfe - Cough Data, Remotely and at scale
Plug and play logo. Hyfe - Cough is now objective, reliable clinical data
Independent logo. Hyfe - AI for humans: save lives, eradicate disease, and stop the next pandemic
News Watch logo. Hyfe - Hyfe AI detects and tracks cough in real-time, remotely and at scale
The sewanee purple logo. Hyfe - Founded to transform healthcare and impact global health through acoustic epidemiology
Pharmaphorum logo. Hyfe - Talk to a clinical trial expert
Sunday world logo. Hyfe - By using artificial intelligence, Hyfe tracks cough frequency and helps you identify cough trends.

Datapoints Processed

Unique Users

Coughs Detected

Countries

Clinical Trials

Hyfe’s CoughMonitor Suite:
Continuous, clinically validated cough monitoring.

Unprecedented, always-on performance in real-world environments.
Featuring a state-of-the-art wearable device, an intuitive companion app, and a comprehensive dashboard.

TRUSTED BY:

Unobtrusive, Clinically Validated, Always-on:
Reliable Results for any Clinical Study.

Hyfe AI can be deployed on any smart device for reliable cough detection, tracking and management at scale.

Continuous Monitoring

Hyfe’s tools provide uninterrupted cough monitoring for weeks, months, or even years, unlike other technologies that are limited to 24-hour or overnight sessions.

Unobtrusive Form Factor

Hyfe’s watch is a familiar, convenient form factor appealing to users of all tech literacy levels and requiring no patient interaction. Its simplicity and ease of use ensures patient compliance and data collection success.

Privacy Preserving

Hyfe’s AI cough detection models run entirely on device, ensuring 100% privacy by analyzing only cough timestamps without recording any sounds.

Clinically Validated

Hyfe’s tools outperform alternatives with consistent, scientifically backed results and very low false positives, as demonstrated in clinical studies. Validation results - 90% sensitivity & 1 FP/ h

Backed by Experience

Hyfe’s processes and services have been honed through 46 global clinical trials, demonstrating reliable performance and precision in scalable cough detection across diverse field research settings.

Trusted By Coughers and Health Providers

Thousands of coughers and health providers worldwide rely on Hyfe’s AI cough detection models daily.

“Our patients have reported that they have found Hyfe’s watch easy to use [...] They particularly like the fact that they do not have to be particularly ‘tech savy’ in order to collect data around their cough. [...] I believe that this technology has a plethora of potential applications in the field of respiratory medicine, in both research and clinical practice.”
Dominic Sykes - University of Hull
FAQ

Cough Monitoring Frequently Asked Questions

Collaboration

Our research partnerships

All over the world

Map image where Hyfe is working and has partners. Hyfe - Acoustic epidemiology is the next frontier in healthcare

CRCHUM & CPAS institutes

Multi-Drug Resistant TB

Vietnam

Rapid Research in Diagnostics Development for TB Network

TB

Vietnam

John Hopkins University

TB

India

World Health Partners

TB

Bihar, India

Geneva University Hospitals (HUG)

Pediatric Bronchiolitis

Geneva, Switzerland

Hospital de Navarra

COVID-19 other respiratory diseases

Navarra-Pamplona, Spain

Sewanee University

COVID-19

Navarra-Pamplona, Spain

CRCHUM & McGill University

COVID-19 and Cystic Fibrosis

Montreal, Canada

New York University

RCC

New York, USA

University of Pittsburgh

TB

Pittsburgh, USA

University of Navarra

Malaria

Mozambique

University of Minnesota

RCC

Minnesota, USA

Fudan University

TB

Shanghai, China

Asan Medical Center

RCC

Korea

ARCIM institute

Pediatric bronchiolitis

Germany

John Hunter Hospital

Asthma

New South Wales, Australia

University of Montreal (CRCHUM)

COVID-19

Brazil

University of Hull

GERd

Hull, UK

FEND

RCC

USA

PAI Life Sciences

NTM

Seattle, USA

Oregon Health Science University

NTM

Oregon, USA

Hospital del Sol

COVID-19

Spain

Rapid Research in Diagnostics Development for TB Network

TB

Uganda

Rapid Research in Diagnostics Development for TB Network

TB

Gambia

Imperial College London

RCC

UK

McGill University

CHF

USA

UF-EPI (Glenn Morris)

COVID-19

Florida, USA

John Hopkins University

TB

Uganda

Montreal (CRCHUM) & McGill University

TB

Peru

The University of Montreal Hospital Research Centre (CRCHUM)

TB

Madagascar

The University of Montreal Hospital Research Centre (CRCHUM)

TB

Tanzania

Rapid Research in Diagnostics Development for TB Network

TB

Phillippines

Rapid Research in Diagnostics Development for TB Network

TB

South Africa

Rapid Research in Diagnostics Development for TB Network

TB

India

Ribeirao Medical School

Pediatric RCC

Brazil

,

Test dot

Country

University

,

Test dot

Country

Learn more about our solutions

Virtual Care

Virtual Care

Monitor cough, remotely and passively, to reduce hospitalisations, save costs and improve outcomes.

Learn More

Life Sciences

Use accurate, non-intrusive cough monitoring to deliver more effective clinical trials from better patient screening to novel study endpoints.

Learn More

Research

Enhance your research toolkit with a meaningful endpoint for one for the world’s most common symptoms.

Learn More